TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer hope: triple therapy shows promise in early trial
Disease control Not yet recruitingThis phase II trial tests a combination of low-dose bevacizumab and atezolizumab (immunotherapy drugs) plus targeted chemotherapy delivered directly to the liver (TACE-HAIC) as a first treatment for people with unresectable hepatocellular carcinoma. About 38 participants will rec…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets unresectable liver cancer
Disease control Not yet recruitingThis study tests a new combination treatment for people with advanced liver cancer that cannot be surgically removed. The treatment includes a procedure that delivers chemotherapy directly to the tumor (TACE) plus two drugs that boost the immune system and block blood vessel grow…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC